SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLTR COULTER PHARMACEUTICAL -- Ignore unavailable to you. Want to Upgrade?

To: Gordon James who wrote (455)12/10/1999 12:40:00 AM
From: Pseudo Biologist  Respond to of 666
 
Gordon, thanks for the detailed reports. It does sound like Dr. Leonard was quite busy. Any comments on the anti-CD22 approach?

biz.yahoo.com

Going back to flurad, chop, etc, you probably saw Peter's post on the cost of treating their side effects. If this is a valid measure, it does look indeed as if flurad alone is quite a bit less toxic than CHOP. Look forward to your analysis of the actual data when one combines these with Bex and Rit, respectively.

PB



To: Gordon James who wrote (455)12/10/1999 2:50:00 AM
From: Vector1  Respond to of 666
 
Gordon, thanks for the informative posts.
V1



To: Gordon James who wrote (455)12/10/1999 7:02:00 PM
From: LLCF  Respond to of 666
 
Thanks so much for the DD... I'll certainly be chipping in on that KEG. :)

DAK



To: Gordon James who wrote (455)12/10/1999 10:03:00 PM
From: Bob L  Read Replies (1) | Respond to of 666
 
Gordon, I join the chorus. Thanks, thanks.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News